Identification of a novel ligand for the ATAD2 bromodomain with selectivity over BRD4 through a fragment growing approach

Organic & Biomolecular Chemistry
Duncan C MillerCeline Cano

Abstract

ATAD2 is an ATPase that is overexpressed in a variety of cancers and associated with a poor patient prognosis. This protein has been suggested to function as a cofactor for a range of transcription factors, including the proto-oncogene MYC and the androgen receptor. ATAD2 comprises an ATPase domain, implicated in chromatin remodelling, and a bromodomain which allows it to interact with acetylated histone tails. Dissection of the functional roles of these two domains would benefit from the availability of selective, cell-permeable pharmacological probes. An in silico evaluation of the 3D structures of various bromodomains suggested that developing small molecule ligands for the bromodomain of ATAD2 is likely to be challenging, although recent reports have shown that ATAD2 bromodomain ligands can be identified. We report a structure-guided fragment-based approach to identify lead compounds for ATAD2 bromodomain inhibitor development. Our findings indicate that the ATAD2 bromodomain can accommodate fragment hits (Mr < 200) that yield productive structure-activity relationships, and structure-guided design enabled the introduction of selectivity over BRD4.

References

Oct 22, 2009·Cancer Research·Marco CiróKristian Helin
Jul 9, 2010·Chemistry & Biology·Paul Workman, Ian Collins
Sep 28, 2010·Nature·Panagis FilippakopoulosJames E Bradner
Feb 16, 2011·Cell Research·Andrew J Bannister, Tony Kouzarides
May 17, 2011·Journal of Medicinal Chemistry·Chun-Wa ChungEdwige Nicodeme
Jul 14, 2012·Journal of Medicinal Chemistry·Lewis R VidlerSwen Hoelder
Apr 23, 2014·Nature Reviews. Drug Discovery·Panagis Filippakopoulos, Stefan Knapp
Apr 26, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Wei-Na WanWen-Jing Zhao
Oct 15, 2014·Journal of Medicinal Chemistry·Mary J HarnerStephen W Fesik
Feb 18, 2015·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Hye Won HwangCheol-Keun Park
May 3, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Pan ShangXiuwei Chen
Jul 15, 2015·Journal of Medicinal Chemistry·Emmanuel H DemontPaul Bamborough
Aug 1, 2015·Journal of Medicinal Chemistry·Paul BamboroughEmmanuel H Demont
Nov 4, 2015·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·M- J ZhangZ- P Chen
Aug 18, 2016·Angewandte Chemie·Paul BamboroughRobert J Watson
Oct 19, 2017·ACS Chemical Biology·Amaury E Fernández-MontalvánMátyás Gorjánácz

❮ Previous
Next ❯

Citations

Jan 10, 2019·ChemMedChem·Michael A CleggPhilip G Humphreys
Jul 28, 2019·Computational Biology and Chemistry·Flávia S ZandonadiJohanna Korvala
Mar 13, 2021·Life Sciences·Aditi NayakAnasuya Roychowdhury
Sep 19, 2018·Journal of Medicinal Chemistry·Paul BamboroughEmmanuel H Demont

❮ Previous
Next ❯

Methods Mentioned

BETA
Isothermal titration calorimetry
homogeneous time-resolved fluorescence

Related Concepts

Related Feeds

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Related Papers

Frontiers in Bioscience : a Journal and Virtual Library
M H DysonL C Mahadevan
Journal of Medicinal Chemistry
Mary J HarnerStephen W Fesik
Bioorganic & Medicinal Chemistry Letters
Hongtao ZhaoAmedeo Caflisch
European Journal of Medicinal Chemistry
Dimitrios SpiliotopoulosAmedeo Caflisch
© 2022 Meta ULC. All rights reserved